Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1998Journal of Clinical Oncology

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.

View Full Paper
Ask AI
Bookmark
Share

Authors

IAIrene L. AndrulisSBShelley B. BullMBMartin E. Blackstein

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Andrulis et al. (1998) studied this question.

synapsesocial.com/papers/6a0ede7a950456576347d548https://doi.org/10.1200/jco.1998.16.4.1340
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neu-Protein Overexpression in Breast Cancer1988 · 867 citations
  2. 2Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group.1993 · 535 citations
  3. 3pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐up1991 · 6,250 citations
  4. 4Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases1989 · 2,314 citations